These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8615501)

  • 21. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
    Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M
    Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses.
    Nelson TE
    Anesthesiology; 1990 Sep; 73(3):449-54. PubMed ID: 2393129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
    Allen PD; López JR; Sánchez V; Ryan JF; Sreter FA
    Anesthesiology; 1992 Jan; 76(1):132-8. PubMed ID: 1729917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suxamethonium-induced porcine malignant hyperthermia.
    Gronert GA; Theye RA
    Br J Anaesth; 1976 Jun; 48(6):513-7. PubMed ID: 952685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
    Allen GC; Fletcher JE; Huggins FJ; Conti PA; Rosenberg H
    Anesthesiology; 1990 Jan; 72(1):71-6. PubMed ID: 2297135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia.
    Gallant EM; Mickelson JR; Roggow BD; Donaldson SK; Louis CF; Rempel WE
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C781-6. PubMed ID: 2801926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia.
    Kindler CH; Girard T; Gong D; Urwyler A
    Anesth Analg; 2002 Apr; 94(4):1028-33, table of contents. PubMed ID: 11916818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desflurane is a trigger of malignant hyperthermia in susceptible swine.
    Wedel DJ; Iaizzo PA; Milde JH
    Anesthesiology; 1991 Mar; 74(3):508-12. PubMed ID: 1900398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
    Fletcher JE; Calvo PA; Rosenberg H
    Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
    Cosgrove SB; Eisele PH; Martucci RW; Gronert GA
    Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of susceptibility to malignant hyperpyrexia in swine.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
    Harrison GG; Dyer RA; Llewellyn RL; James MF
    Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane.
    Foster PS; Hopkinson KC; Denborough MA
    Br J Anaesth; 1989 May; 62(5):560-5. PubMed ID: 2730829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-chloro-m-cresol triggers malignant hyperthermia in susceptible swine at doses greatly exceeding those found in drug preparations.
    Iaizzo PA; Johnson BA; Nagao K; Gallagher WJ
    Anesthesiology; 1999 Jun; 90(6):1723-32. PubMed ID: 10360872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preanesthetic evaluation and management of malignant hyperthermia in the pig experimental model.
    Short CE; Paddleford RR; McGrath CJ; Williams CH
    Anesth Analg; 1976; 55(5):643-53. PubMed ID: 987720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
    Fletcher JE; Rosenberg H
    Br J Anaesth; 1986 Dec; 58(12):1433-9. PubMed ID: 3790395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.